Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials
Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G., Goubar, A., Ficarra, G., Griguolo, G., Conte, PJournal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-017-4219-3
Date:
April, 2017
File:
PDF, 301 KB
2017
File converter
More search results
More benefits 
